Join the Lung Cancer group to help and get support from people like you.
Lung Cancer News (Page 3)
Related terms: Cancer, Bronchogenic Carcinoma, Cancer, Lung
Few High-Risk Individuals Have Heard of, Discuss Lung Cancer Screening
TUESDAY, Nov. 12, 2024 – Few high-risk individuals have heard of or have discussed lung cancer screening (LCS) with a health care practitioner, according to a research letter published online Oct....
Early Steps to a Breath Test for Lung Cancer
THURSDAY, Nov. 7, 2024 – An experimental portable device might be able to detect lung cancer from a person’s exhaled breath, researchers report. The device contains “nanoflake” sensors that can detec...
Sensitivity Reduced on Low-Dose Pediatric CT Scans for Small Lung Nodules
MONDAY, Oct. 21, 2024 – Two lung-nodule computer-aided detection (CAD) systems demonstrated reduced sensitivity on low- versus standard-dose computed tomography (CT) scans for small nodules in...
Tobacco-Free Generation Could Prevent 40 Percent of Predicted Lung Cancer Deaths Globally
MONDAY, Oct. 7, 2024 – Implementation of a tobacco-free generation could substantially reduce global lung cancer mortality, according to a study published in the October issue of The Lancet Public ...
Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
Cambridge, UK. AstraZeneca Press Release--26 September 2024--AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the treatment of adult patients with unresectable, Stage III e...
Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
MONDAY, Sept. 30, 2024 – The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according to a study published online Sept. 24 in the...
Wearable Tied to Better Physical Activity Recovery Following Lung Cancer Surgery
WEDNESDAY, Sept. 25, 2024 – A postoperative wearable device may improve physical activity and patient-reported dyspnea at six months after lung cancer surgery, according to a study published online...
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
THURSDAY, Sept. 19, 2024 – For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to...
Early, Virtual Palliative Care Feasible for Advanced Lung Cancer
TUESDAY, Sept. 17, 2024 – The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with advanced non-small cell lung cancer (NSCLC),...
Perioperative Nivolumab Beneficial for Resectable NSCLC
THURSDAY, Sept. 12, 2024 – For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free survival (EFS) benefit compared with neoadjuvant...
Alternative Explanation Conditions Often Delay Lung Cancer Diagnosis
WEDNESDAY, Sept. 11, 2024 – Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in...
Lung Complications + Rheumatoid Arthritis Increase Risk for Lung Cancer
FRIDAY, Sept. 6, 2024 – The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study published online Sept. 3 in Modern Rheumatology. ...
FDA Approves Tabrecta (capmatinib) for Metastatic Non-Small Cell Lung Cancer with METex14
EAST HANOVER, N.J., May 6, 2020 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) approved Tabrecta™ (capmatinib, formerly INC280), an oral MET inhibitor for adul...
FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
South San Francisco, CA – March 18, 2019 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq...
FDA Approves Keytruda (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
KENILWORTH, N.J.--(BUSINESS WIRE) October 30, 2018 --Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...